Philippe started his healthcare career more than 25 years ago. After graduating from Universite Rene Descartes – Paris V, Philippe worked for several pharmaceutical companies and launched 15 medicines and vaccines across multiple therapeutic areas: CNS, Women's Health, Cardiovascular, Oncology, Immunology, Hemophilia, Dermatology/Hair loss, and Meningitis. Most of his career was with Pfizer, first in France, as a product manager for Zoloft; he led the launch of 2 key indications, OCD and recurrent depression. After moving to NY global headquarter, he held strategic and operational roles with the accountability for clinical, regulatory, and commercial strategies for phase 2/3 assets. For the past ten years at Pfizer, Philippe led market access teams responsible for designing and building fit-for-purpose global value strategies and tools, enabling local teams to win reimbursements in Europe, Asia, China, and Africa Middle East for medicines and vaccines. Most recently, Philippe co-founded OptiChroniX, a digital health startup developing a software as a medical device that Alzheimer's patient associations should be willing to champion, healthcare providers willing to prescribe, and payers willing to reimburse. Philippe is also a mentor and advisor to MedTech and life science startup founders.